Delivery Order SPE2DB24D9223-SPE2DB25FKEKC
- Not listed
- On July 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $487,498.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order is expected to be completed by August 8, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, which is scheduled for completion by August 22, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor on this award. The delivery order is...
- This delivery order, issued on August 8, 2025, by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, covers the supply of Stelara 90 mg/ml syringes with a ceiling value of $16,249.95. The contract is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, represents a tactical purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48,749.85 on August 11, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, was issued without a set-aside designation by the Medical Supply Chain, a defense-focused federal agency. The contract represents a fulfillment of pharmaceutical supply...
- The Defense Logistics Agency awarded a $65,000 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This delivery order, issued on July 31, 2025, represents an individual task order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $500 million and extending through November 2026. The delivery order carries an...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, was executed without a set-aside designation. The delivery is scheduled for the Park Ridge, IL location, and represents a specific...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a single transaction under the company's larger Indefinite Delivery Contract with DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, valued at $16,249.95, is scheduled for completion by August 20, 2025, with performance at the contractor's Park Ridge facility. The award carries no set-aside designation, reflecting the company's competitive...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKEKCDelivery Order
On August 11, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract calls for the delivery of Stelara 90 mg/ml syringes, with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's competitive positioning as a woman-owned small business in the federal pharmaceutical procurement market. DMS Pharmaceutical Group is operating under a larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion and valid through November 2026, which enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting Department of Defense healthcare facilities worldwide. The vendor's established portfolio includes distribution of branded and generic prescription drugs, biologics, and medical consumables across multiple therapeutic categories. This delivery order for Stelara, a specialty pharmaceutical product used in treating various immune-mediated conditions, represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain supporting military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/11/25 |